23-Hydroxytormentic acid and niga-ichgoside F1 isolated from Rubus coreanus attenuate cisplatin-induced cytotoxicity by reducing oxidative stress in renal epithelial LLC-PK1 cells

Biological and Pharmaceutical Bulletin

Volumn 34, Issue 6, 2011, Pages 906-911

  Kim, Yang Hee ^a,b   Choi, Jung Hye ^a   Rim, Hong Kun ^a,b   Kang, Hyun Jun ^a   Chang, Sung Goo ^b   Park, Jae Hoon ^b   Park, Hee Juhn ^c   Choi, Jong Won ^d   Kim, Soo Dong ^e   Lee, Kyung Tae ^a,b  

^a Kyung Hee University   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

^c Sangji University   (South Korea)

^d Kyungsung University   (South Korea)

^e Dong A University   (South Korea)

Author keywords

23 Hydroxytormentic acid; Antioxidant enzyme; Nephrotoxicity; Niga ichigoside F1; Nuclear factor erythroid 2 related factor 2; Oxidative stress

Indexed keywords

23 HYDROXYTORMENTIC ACID; ANTIOXIDANT; CATALASE; GLUTATHIONE; GLYCOSIDE; MALONALDEHYDE; MANGANESE SUPEROXIDE DISMUTASE; NIGA ICHIGOSIDE F1; REACTIVE OXYGEN METABOLITE; TORMENTIC ACID; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG ISOLATION; DRUG MECHANISM; DRUG STRUCTURE; ENZYME ACTIVITY; EPITHELIUM CELL; KIDNEY EPITHELIUM; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; RENAL PROTECTION; ROSACEAE; RUBUS COREANUS; SWINE; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; APOPTOSIS; CELL LINE; CELL NUCLEUS; CELL SURVIVAL; CISPLATIN; EPITHELIAL CELLS; FRUIT; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUTATHIONE; GLYCOSIDES; KIDNEY; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; OXIDOREDUCTASES; PROTEIN TRANSPORT; RNA, MESSENGER; ROSACEAE; SUS SCROFA; TRITERPENES;

EID: 79958017512     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.34.906     Document Type: Article

References (44)

1. Pabla N., Dong Z., Kidney Int., 73, 994-1007 (2008).
2. Kuhlmann M. K., Burkhardt G., Köhler H., Nephrol. Dial. Transplant., 12, 2478-2480 (1997).
3. Tsuruya K., Ninomiya T., Tokumoto M., Hirakawa M., Masutani K., Taniguchi M., Fukuda K., Kanai H., Kishihara K., Hirakata H., Iida M., Kidney Int., 63, 72-82 (2003).
4. Yao X., Panichpisal K., Kurtzman N., Nugent K., Am. J. Med. Sci., 334, 115-124 (2007).
5. Masuda H., Tanaka T., Takahama U., Biochem. Biophys. Res. Commun., 203, 1175-1180 (1994).
6. Chirino Y. I., Pedraza-Chaverri J., Exp. Toxicol. Pathol., 61, 223-242 (2009).
7. Ahn H., Lee E., Kim K., Lee C., J. Urol., 151, 263-267 (1994).
8. Yoshida M., Fukuda A., Hara M., Terada A., Kitanaka Y., Owada S., Life Sci., 72, 1773-1780 (2003).
9. Appenroth D., Fröb S., Kersten L., Splinter F. K., Winnefeld K., Arch. Toxicol., 71, 677-683 (1997).
10. Naziroglu M., Karaoglu A., Aksoy A. O., Toxicology, 195, 221-230 (2004).
11. Maliakel D. M., Kagiya T. V., Nair C. K., Exp. Toxicol. Pathol., 60, 521-527 (2008).
12. Davis C. A., Nick H. S., Agarwal A., J. Am. Soc. Nephrol., 12, 2683-2690 (2001).
13. Oh M. S., Yang W. M., Chang M. S., Park W., Kim R., Lee H. K., Kim W. N., Park S. K., J. Ethnopharmacol., 114, 463-467 (2007).
14. Jung Y. J., Youn J. Y., Ryu J. C., Surh Y. J., Mutat. Res., 474, 25-33 (2001).
15. Park H. J., Jung W. T., Basnet P., Kadota S., Namba T., J. Nat. Prod., 59, 1128-1130 (1996).
16. Choi J., Lee K. T., Ha J., Yun S. Y., Ko C. D., Jung H. J., Park H. J., Biol. Pharm. Bull., 26, 1436-1441 (2003).
17. Nam J. H., Jung H. J., Choi J., Lee K. T., Park H. J., Biol. Pharm. Bull., 29, 967-970 (2006).
18. Yang H. M., Oh S. M., Lim S. S., Shin H. K., Oh Y. S., Kim J. K., Phytother. Res., 22, 102-107 (2008).
19. Yun K. J., Kim J. Y., Kim J. B., Lee K. W., Jeong S. Y., Park H. J., Jung H. J., Cho Y. W., Yun K., Lee K. T., Int. Immunopharmacol., 8, 431-441 (2008).
20. Kim D. H., Lee K. T., Bae E. A., Han M. J., Park H. J., Arch. Pharm. Res., 22, 30-34 (1999).
21. Bellosillo B., Dalmau M., Colomer D., Gil J., Blood, 89, 3378-3384 (1997).
22. Dahle L. K., Hill E. G., Holman R. T., Arch. Biochem. Biophys., 98, 253-261 (1962).
23. Eyer P., Podhradsky D., Anal. Biochem., 153, 57-66 (1986).
24. Misra H. P., Fridovich I., J. Biol. Chem., 247, 3170-3175 (1972).
25. Aebi H., Methods Enzymol., 105, 121-126 (1984).
26. Paglia D. E., Valentine W. N., J. Lab. Clin. Med., 70, 158-169 (1967).
27. Cummings B. S., Schnellmann R. G., J. Pharmacol. Exp. Ther., 302, 8-17 (2002).
28. Griendling K. K., Ushio-Fukai M., Regul. Pept., 91, 21-27 (2000).
29. Caballero-George C., Vanderheyden P. M., Okamoto Y., Masaki T., Mbwambo Z., Apers S., Gupta M. P., Pieters L., Vauquelin G., Vlietinck A., Phytother. Res., 18, 729-736 (2004).
30. Goldstein R. S., Mayor G. H., Life Sci., 32, 685-690 (1983).
31. Basnakian A. G., Kaushal G. P., Shah S. V., Antioxid. Redox Signal., 4, 915-924 (2002).
32. Singh G., Toxicology, 58, 71-80 (1989).
33. Huang Z. Z., Chen C., Zeng Z., Yang H., Oh J., Chen L., Lu S. C., FASEB J., 15, 19-21 (2001).
34. Safirstein R., Miller P., Guttenplan J. B., Kidney Int., 25, 753-758 (1984).
35. Pedraza-Chaverrí J., Maldonado P. D., Medina-Campos O. N., Olivares-Corichi I. M., Granados-Silvestre M. A., Hernández-Pando R., Ibarra-Rubio M. E., Free Radic. Biol. Med., 29, 602-611 (2000).
36. Gilgun-Sherki Y., Melamed E., Offen D., Neuropharmacology, 40, 959-975 (2001).
37. Wu G., Fang Y. Z., Yang S., Lupton J. R., Turner N. D., J. Nutr., 134, 489-492 (2004).
38. Mistry P., Merazga Y., Spargo D. J., Riley P. A., McBrien D. C., Cancer Chemother. Pharmacol., 28, 277-282 (1991).
39. Zhang J. G., Lindup W. E., Biochem. Pharmacol., 45, 2215-2222 (1993).
40. McCord J. M., Roy R. S., Schaffer S. W., Adv. Myocardiol., 5, 183-189 (1985).
41. Garattini E., Fratelli M., Terao M., Cell. Mol. Life Sci., 65, 1019-1048 (2008).
42. Sies H., Masumoto H., Adv. Pharmacol., 38, 229-246 (1997).
43. Wasserman W. W., Fahl W. E., Proc. Natl. Acad. Sci. U.S.A., 94, 5361-5366 (1997).
44. Andlauer W., Kolb J., Fürst P., J. Nutr., 130, 3021-3027 (2000).